• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CELLESTIS LIMITED QUANTIFERON TB GOLD; NONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CELLESTIS LIMITED QUANTIFERON TB GOLD; NONE Back to Search Results
Device Problems False Positive Result (1227); Nonstandard Device (1420)
Patient Problem Emotional Changes (1831)
Event Date 06/12/2012
Event Type  malfunction  
Event Description
The pt (b)(6) claims that he was tested and found to be (b)(6) for (b)(6) based on the use of a cellestis quantiferon tb gold test.The assumption is the test was performed on a lot of (b)(6)tubes which were recalled by the firm (ref 3003964343-01/28/13-001-r).The pt was put on treatment with (b)(6).After receiving notification of the recall, the pt was retested on (b)(6) 2012 which was found to be (b)(6) for (b)(6).The pt claims that he suffered emotionally from this incident.
 
Manufacturer Narrative
As a result of a capa investigation, past legal communication was found that was identified as requiring a medwatch report.The company has decided to submit this mdr for information purposes in an abundance of caution and to ensure full compliance with 21 cfr part 803.Based upon the intended use of the product, if a positive result is obtained, the physician is advised to repeat the test for confirmation, and in general the results of the screening test are to be taken into consideration with the patient's epidemiological history, current medical status and results of other diagnostic evaluations.The alleged problems reported are the outcome of diagnosis, and subsequent treatment of the pt using (b)(6).Cellestis filed notification of their voluntary recall through the regional fda district recall office on 10/16/2012.Closure of the recall by the fda was received 4/25/2013.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QUANTIFERON TB GOLD
Type of Device
NONE
Manufacturer (Section D)
CELLESTIS LIMITED
chadstone, victoria
AS 
Manufacturer Contact
donna sowers
19300 germantown rd
germantown, MD 20874
2406867876
MDR Report Key4747518
MDR Text Key17214375
Report Number3003964343-2015-00001
Device Sequence Number1
Product Code NCD
Combination Product (y/n)N
PMA/PMN Number
P010033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Not Applicable
Remedial Action Recall
Type of Report Initial
Report Date 04/30/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/01/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received07/04/2013
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number3003964343-01/28/13-001-
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age30 YR
-
-